Program Schedule

39
Antibiotic Stewardship

Thursday, October 9, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Health care workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Pharmacists

Tracks: Adult ID, Epidemiology and Infection Control, Pediatric ID

Presentations:
135
Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
Lilian Abbo, MD ; Aida Casiano-Colón, PhD ; Marissa Tysiak, PharmD ; Thomas M. Hooton, MD
137
Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
Ryan Fagan, MD ; Nicole Gualandi, RN, MS/MPH ; Zintars G. Beldavs, MS ; Ghinwa Dumyati, MD ; Marion Kainer, MBBS, MPH ; Ruth Lynfield, MD ; Meghan Maloney, MPH ; Jea-Young Min, PharmD, MPH ; Joelle Nadle, MPH ; Susan M. Ray, MD, FIDSA ; Katherine Richards, MPH ; Scott Fridkin, MD ; Shelley S. Magill, MD, PhD
138
Do Criteria-Based Urine Cultures Contribute to Unnecessary Antibiotic Use at a Community Teaching Hospital?
Kayla Uganski, Pharm.D. ; Kasey Bucher, Pharm.D. ; G. Robert Deyoung, PharmD ; Nnaemeka Egwuatu, MD, MPH ; Andrew Weise, MD ; Jessica Prusa, Pharm.D. ; Lisa Dumkow, Pharm.D.
139
Descriptive study of patterns of urine testing and antibiotic use in an inpatient physical medicine and rehabilitation population
Christina Andrzejewski, PharmD ; Kathleen Shutt, MS ; Henry Freedy, PharmD ; Gary Galang, MD ; Mohamed Yassin, MD, PhD
140
Improved Practice and Decreased Antibiotic Utilization for Urinary Indications in Long Term Care Facilities After an Educational Intervention
Shira Doron, MD, MS ; Nora Mcelroy, MPH ; Susanne Salem-Schatz, ScD ; Paula Griswold, MS ; Daniel Pallin, MD MPH ; Ruth Kandel, MD ; Eileen Mchale, RN, BSN ; Nathaniel Simmons, MS ; Alfred Demaria Jr., MD
141
Urine Culture Optimization: A Powerful Antimicrobial Stewardship Strategy
Barley Chironda, RPN, CIC ; Jeff Powis, MD, MSc, FRCPC
142
Retrospective, multicenter, point prevalence study of urinary tract infection (UTI) data for a city-wide antimicrobial stewardship initiative
Chas Hoffmann, PharmD ; Emily Sydnor, MD, MHS ; Mary Lourdes Brundige, PharmD ; Shashi Patel, PharmD ; Christopher Evans, PharmD ; Elizabeth Rightmier, PharmD ; Mary Staicu, PharmD ; Christina Felsen, MPH ; Elizabeth Dodds Ashley, PharmD, MHS ; Ghinwa Dumyati, MD
Posters
  • IDWeek Poster v2.0.pdf (467.5 kB)
  • 143
    The Frequency of Antibiotic Treatment of Positive Urine Cultures in Hospitalized Patients that are not UTIs: A Three Hospital Survey
    Loren Miller, MD, MPH ; Katherine Kahn, MD ; Samantha J. Eells, MPH ; Seong Choi, MD ; Maya Riva, PharmD ; Marianne Go-Wheeler, MD ; Tanzib Hossain, MD ; Jonathan Grein, MD
    144
    Unexpected Intramuscular Ceftriaxone Prescribing Patterns in a Multi-campus Ambulatory Care Health System
    Teresa Geide, Pharm.D., BCPS ; Melissa Ignacio, ANP-BC, CIC ; Jennifer C. Thompson, MD, MPH, FIDSA
    146
    Review of Empiric Echinocandin Therapy for Candidemia
    Cristina Amado, MD ; Paul Blair, MD ; Marc Siegel, MD ; John Keiser, MD
    Posters
  • CRISTINA_POSTER FINAL.pdf (320.9 kB)
  • 147
    An antibiotic stewardship program in the emergency department decreased piperacillin-tazobactam use and increased guideline-concordant antibiotic prescribing for uncomplicated cystitis
    Michelle Haas, MD ; Bryan Knepper, MPH, MSc ; Kevin Kaucher, PharmD ; Kati Shihadeh, PharmD ; Jeffrey Sankoff, MD ; Timothy Jenkins, MD
    149
    Impact of a  Clinical Decision Support Tool in the Emergency Department on Antimicrobial Prescribing Patterns for the Treatment of Pneumonia
    Danielle Evans, PharmD ; Nishaminy Kasbekar, PharmD, FASHP ; Judith O'donnell, MD ; Tanya Dougherty, PharmD, BCPS ; Richard Maniglia, MD ; Christian Boedec ; Christopher Edwards, MD ; Amanda Binkley, PharmD, AAHVIP
    150
    Changes in Nursing home Reimbursement Associated with Improvement of Antibiogram Data in an Urban Community Hospital
    Kevin Mcdonough, BS, PharmD , MPA ; Samya Shafi, MD ; Elizabeth Mammen-Prasad, MD ; Diana Finkel, DO
    151
    Is Nursing Home Specific Antibiogram Necessary for All Nursing Homes?
    Kaushal Shah, MD ; Paul Cook, MD ; Tae Lee, MD ; Muhammad Salman Ashraf, MD ; John Christie, MD, PhD ; Xiangming Fang, PhD
    152
    One year impact of clindamycin and ciprofloxacin administration on the human normal microflora
    Mamun-Ur Rashid, MD, PhD ; Andrej Weintraub, PhD ; Carl Erik Nord, PhD, MD
    Posters
  • 152_IDWPOSTER.pdf (445.7 kB)
  • 153
    Implementation of a Provider-Based Antimicrobial Stewardship Strategy at a Long Term Acute Care Hospital (LTACH) and Inpatient Physical Medicine and Rehabilitation (PMR) Facility
    Kiri Rolek, PharmD ; Naasha Talati, MD ; Shawn Binkley, BS, PharmD ; Daniel Timko, PharmD, BCPS, AQID ; Steven Morgan, PharmD, BCPS, AQID ; David Pegues, MD, FIDSA, FSHEA ; Keith Hamilton, MD
    154
    Gap Analysis of infection control practices in low and middle income countries (LMIC): Role of antimicrobial stewardship
    Kristy Weinshel, MBA ; Angela Dramowski, MD ; Katerina Mougkou, MD ; Chimanjita Phukan, MD ; Agnes Hajdu, MD ; Maria Staneloni, MD ; Saul Jacob ; Nalini Singh, MD, MPH, FIDSA, FSHEA
    155
    Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013
    Carlos Arturo Alvarez Moreno, Physician infectious diseases ; David Leonardo Mantilla Borda, hiv medical expert
    157
    Effect of Antimicrobial Stewardship Program (ASP) on Perioperative Antibiotic Use in Cardiovascular Surgery in Japanese Tertiary Hospital
    Hideaki Kato, MD ; Hiroko Sosa ; Yoshifumi Sugiyama ; Haruyo Kawahara ; Masaaki Mori, MD, PhD ; Takayuki Kariya, MD ; Masahide Ohtsuka, MD, PhD ; Keiji Uchida, MD, PhD ; Yoshiaki Ishigatsubo, MD, PhD ; Takeshi Kaneko, MD, PhD
    Posters
  • IDweek2014_157.pdf (2.8 MB)
  • 158
    Trends of Antibiotic Consumption in Korea according to Nation-wide Reimbursement Data (2008-2012): A Population-Based Epidemiologic Study
    Young Kyung Yoon, M.D., Ph.D. ; Gi Chan Park ; Hyonggin An, Ph.D. ; Byung Chul Chun, M.D., Ph.D. ; Jang-Wook Sohn, M.D., Ph.D. ; MIN JA KIM, M.D., Ph.D.
    159
    Clinical pharmacists enhance an antimicrobial stewardship program in Thailand
    Anucha Apisarnthanarak, MD ; Pimpun Lapcharoen, PharmD ; Pitcha Vanichkul ; Tananat Srisaeng-Ngoen, PharmD ; Linda Mundy, MD
    160
    A Simulation Study to Assess Indicators of Antimicrobial Use as Predictors of Resistance
    Elise Fortin, PhD(c) ; Caroline Quach, MD MSc FRCPC ; Patricia Fontela, MD PhD ; David L Buckeridge, MD PhD ; Robert W Platt, PhD
    161
    Do Positive Anaerobic Culture Results Affect Physicians’ Clinical Management Decisions?
    Schweta Arakali, MD ; Tilly Varughese, MD ; Susan Boruchoff, MD ; Tanaya Bhowmick, MD
    162
    Antimicrobial Stewardship in the Micro Lab: Selective Susceptibility Reporting and Impact on Ciprofloxacin Utilization in a Hospital Setting
    Bradley Langford, B.Sc.Phm., ACPR, PharmD(c) ; Jenny Seah, B.Sc.Phm., PharmD(c) ; Jennie Johnstone, MD ; Mark Downing, MD ; Dominic Lehnert, MD
    Posters
  • 162 IDWposter.pdf (722.4 kB)
  • 164
    Lessons Learned from Early Implementation of Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF MS) with Antimicrobial Stewardship, A Pilot Study
    Connie Park, MD ; Wendy Szymczak, PhD, MT ; Iona Munjal, MD ; Michael Levi, ScD, (D) ABMM ; Phillip Gialanella, MS ; Yi Guo, PharmD ; Julie E. Williamson, PharmD ; Philip Chung, PharmD, MS ; Rafael Ruiz, PhD, ScM ; Priya Nori, MD ; Belinda Ostrowsky, MD, MPH
    165
    Integrating a Rapid Diagnostic Test and Antimicrobial Stewardship: Optimizing Discharge Antibiotics in Skin and Soft Tissue Infections (SSTI)
    Diana Yu, PharmD, BCPS ; Leslie Stach, PharmD, BCPS ; Jason Newland, MD ; Rangaraj Selvarangan, PhD ; Jennifer Goldman, MD
    Posters
  • IDSA SSTI PBP2a 100214.pdf (126.7 kB)
  • 166
    Rapid MRSA PCR on Respiratory Specimens from Ventilated Patients with Suspected Pneumonia: A Potential Tool for Antimicrobial Stewardship
    Sergio E. Trevino, MD ; Morgan a. Pence, PhD ; Jonas Marschall, MD ; Marin H. Kollef, MD ; Hilary M. Babcock, MD, MPH ; Carey-Ann D. Burnham, PhD
    167
    Reduction in Contaminated Blood Culture Rates and Associated Costs as an Antimicrobial Stewardship Program Activity
    John Toney, MD ; Narla Fries, CLS, MT(ASCP) ; Rey Rivera, MD ; Stephen Mastorides, MD ; Richard Oehler, MD, FACP, FIDSA ; Sandra Gompf, MD
    Posters
  • 167_IDWPOSTER.pdf (1004.9 kB)
  • 168
    The Positive Blood Culture as a Stewardship Opportunity: Time to Appropriate and "Best Therapy" is a Useful Quality Gauge Across an Acute Care Hospital
    Lynora Saxinger, MD FRCPC ; Stephanie De Champlain, BScPharm, PharmD Candidate 2014 ; Micheal Guirguis, BScPharm, PhD
    Posters
  • ID WEEK 2014bloodculture.pdf (651.1 kB)
  • 169
    Rapid Testing using Verigene® Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-negative Bacteremia
    Jacqueline T. Bork, MD ; Surbhi Leekha, MBBS, MPH ; Emily Heil, PharmD ; Rilwan Badamas, PharmD Candidate ; J. Kristie Johnson, PhD
    171
    Impact of Rapid Bloodstream Pathogen Identification in Hospitalized Patients
    Matthew Maslonka, MD ; Alison G. Freifeld, MD ; Mark E. Rupp, MD ; Devon Greer, PharmD ; Robbe Peetz, PA ; Elizabeth Lyden, MS ; Paul D. Fey, PhD ; Trevor C. Van Schooneveld, MD
    172
    Can Procalcitonin (PCT) Be Used as an Early Marker of Sepsis in Patients with Intracranial Hemorrhage (ICH)?
    Pranisha Gautam-Goyal, MD ; Arthur Luka, MD ; Prashant Malhotra ; Marcia Epstein, MD ; David Ledoux, MD ; Lisa George, MD ; Erfan Hussain, MD ; Rebecca Schwartz, PhD ; Celine Rahman Dematteo ; Reuben Burshtein
    173
    Introduction of Procalcitonin Testing Did Not Reduce Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    Krishna Rao, MD ; Daniel Mcclung, MD ; Bonnie Wang, MD ; Spencer Winters, MD ; Scott Flanders, MD
    175
    Cost-effectiveness of a Procalcitonin-Guided Treatment Algorithm in Sepsis
    Curtis Collins, PharmD, MS ; Michelle Harrison, PharmD
    176
    Antibiotic Prescribing Adherence to Procalcitonin (PCT)-Generated Recommendations in Two Academic Medical Intensive Care Units (MICUs)
    David N. Schwartz, MD ; Jon Cooke, MD ; Sarah Rebecca Peglow, MD ; Rosie D. Lyles, MD, MHA ; Renaud Gueret, MD ; Renee Xamplas, PharmD ; Kamaljit Singh, MD ; Waldemar Niklinski, MD ; Ryan Cypser ; Louis Fogg, PhD ; Robert A Weinstein, MD ; Robert Balk, MD
    Posters
  • IDWeek_2014_PCT v3.pdf (679.0 kB)
  • 178
    Impact of Delaying methicillin-resistant Staphylococcus aureus (MRSA) Pneumonia Treatment Until Microbiologic Documentation
    Kelcey Noble, PharmD ; Adam Pesaturo, PharmD ; Erica Housman, PharmD ; William Mcgee, M.D. ; Alexander Knee
    Posters
  • MRSA PNA ID Week 2014 Noble.pdf (580.8 kB)
  • 181
    Empiric Coverage of ICU Patients for Infections Due to Beta-lactam Resistant Pseudomonas aeruginosa with Combination Therapy: A Needs Assessment
    Kelly Cawcutt, MD ; Lynn Estes, PharmD ; William Marshall, M.D. ; James Steckelberg, MD ; Larry M. Baddour, MD
    182
    Correlation between Antibiotic Use and E.coli Resistances in a Swiss Tertiary Care Hospital
    Alexia Cusini, M.D. ; David Herren ; Andreas Kronenberg, M.D. ; Jonas Marschall, M.D.
    184
    Prevalence and Molecular Epidemiology of ESBL producing E.coli and K.pneumoniae in Lebanese Medical Centers; Strong Correlation between Antibiotic Consumption and Resistance to Cephalosporins and Ciprofloxacin
    Ziad Daoud, Ph.D ; Elie Salem-Sokhn, PhD ; Jihad Irani, MD ; Katia Cheaito, MS ; Nathaline Haidar-Ahmad, MS ; Ghassan Matar, PhD ; Shira Doron, MD, MS
    Posters
  • E. coli poster final edit.pdf (271.7 kB)
  • 185
    Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use
    Elise Fortin, PhD(c) ; Robert W Platt, PhD ; Patricia Fontela, MD PhD ; David L Buckeridge, MD PhD ; Caroline Quach, MD MSc FRCPC
    186
    Incidence of acute kidney injury in patients receiving vancomycin and pipercillin-tazobactam compared to other antibiotic combinations
    Morgan Scully, MD ; Ali Hassoun, MD FACP ; Farrah Ibrahim, MD FACP ; Samuel Lindquist ; Andrew Mameli ; Sarah Jones ; Anthony Anderson
    Posters
  • VancZosyn ID 2014.pdf (868.6 kB)
  • 187
    Colistin and its Effect on Renal Function: A Retrospective Review at an Urban Hospital
    Theodore Markou, MD ; Jason Zucker, MD ; Shin-Pung Jen, PharmD ; David Cennimo, MD
    188
    Evaluation of Baseline QTc Interval and Azithromycin Prescribing in an Academic Medical Center
    Rachael Lee, MD ; Allison Guyton ; Danielle Kunz, R.Ph, BCPS-(AQ) Infectious Disease ; Craig Hoesley, MD
    Posters
  • IDWeek Rachael Lee.pdf (592.6 kB)
  • 189
    Hospital onset Clostridium difficile infection not a predictor of increased antibiotic use in small hospitals: an evaluation of 54 hospitals
    Roy Guharoy, PharmD, MBA ; Mohamad G. Fakih, MD, MPH ; Jeffrey Seggerman, MBA ; Angelo Bufalino, Ph.D. ; Michelle Heavens, BSN, MHA ; Ann Hendrich, RN, PhD
    Posters
  • Cdiff-IDSA-14.pdf (201.3 kB)
  • 190
    Posters
  • Lam 2014.pdf (566.5 kB)
  • 191
    Evaluation of Oxacillin Consumption Following Implementation of a Usage Restriction Protocol: A Drug Use Evaluation and Cost Savings Analysis
    Elise Gilbert, PharmD ; Nathaniel J. Rhodes, PharmD ; Marc Scheetz, PharmD, MSc ; Sarah Sutton, MD ; Teresa Zembower, MD, MPH ; Viktorija Barr, PharmD ; John Esterly, PharmD
    192
    Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
    Haley Morrill, PharmD ; Aisling Caffrey, PhD, MS ; Eunsun Noh, PhD, MS ; Kerry Laplante, PharmD
    Posters
  • IDweek 2014 Vanco.pdf (663.4 kB)
  • 193
    Impact of Weight Based Dosing Guidelines on Vancomycin Dosing and Trough Levels Including in Obese Patients
    Erlaine F. Bello, M.D. ; Koh Okamoto, M.D. ; James Davis, PhD ; Lois Dement, PharmD ; Teppei Shimasaki, M.D.
    Posters
  • idweek poster.pdf (589.7 kB)
  • 194
    Antimicrobial Stewardship Evaluation of Meropenem Use at a Large Academic Medical Center
    Yanina Dubrovskaya, PharmD ; Justin Siegfried, PharmD ; Marco R. Scipione, PharmD ; Donald Chen, MD ; Michael Phillips, MD ; John Papadopoulos, PharmD
    195
    Rapid Intravenous Antibiotic Desensitization: Clinical Experience at a Single Center
    Katelyn Booher, DO ; Kunal Desai, MD ; Steven a. Burdette, MD, FIDSA ; Ronald Markert, PhD ; Craig Pleiman, PharmD ; Hari Polenakovik, MD
    197
    Beta-Lactam Allergy: Documentation Matters
    Nirav Shah, MD, MPH ; Jessica P. Ridgway, MD ; Natasha Pettit, PharmD ; Ari Robicsek, MD
    198
    Evaluation of Antibiotic Use in the Neonatal Intensive Care Unit (NICU): from an Antimicrobial Stewardship (AMS) perspective
    Joseph Ting, MBBS, FRCPC, MPH ; Karen Ng, B.Sc. Pharm., PharmD ; Simon Dobson, MD, FRCPC ; Peter Tilley, MD, FRCPC ; Horacio Osiovich, MD, FRCPC ; Don Hamilton, BSc.Pharm. ; Srinivas Murthy, MD, FRCPC ; Ashley Roberts, MD, M.Ed., FRCPC
    199
    Mandatory Antimicrobial Stewardship Program Review of Pediatric OPAT: Program Implementation and Results of Pilot Phase
    Elizabeth Doby, MD ; Lauren Allen, BA ; Chris Stockmann, MSc ; Jared Olson, PharmD ; Emily a. Thorell, MD, MSci ; Andrew Pavia, MD, FIDSA, FSHEA ; Adam L. Hersh, MD, PhD
    200
    What Triggers an Antimicrobial Stewardship Program (ASP) Intervention in Pediatrics?
    Jennifer Goldman, MD ; Brian Lee, MPH, PhD ; Adam L. Hersh, MD, PhD ; Diana Yu, PharmD, BCPS ; Leslie Stach, PharmD, BCPS ; Angela Myers, MD, MPH ; Mary Anne Jackson, MD, FIDSA ; James Day, MD ; Russell Mcculloh, MD ; Jason Newland, MD
    201
    Evaluation of Antimicrobial Stewardship Computer-Assisted Guidance for the Optimal Use of Amphotericin B
    Sarah Baggett, PharmD ; Thomas Talbot, MD, MPH ; Patty Wright, MD ; Tatsuki Koyama, PhD ; Julius Kirui ; Whitney Jones, PharmD, BCPS
    202
    Antifungal Stewardship: The Clinician’s Perspective on Barriers to Implementation
    Amar Safdar, MD ; Debra Goff, PharmD, FCCP ; Jason Gallagher, PharmD, FCCP, BCPS ; Donald Hsu, PharmD ; Edward Eiland, PharmD, MBA, BCPS-ID, FASHP ; Jennifer Hanrahan, DO ; Purvi Smith, MS, MPH ; Nkechi Azie, MD
    Posters
  • AFSPoster_Safdar_IDWeek2014.pdf (665.2 kB)
  • 203
    Optimization of Posaconazole (PCZ) Dosing with Multi-disciplinary Therapeutic Monitoring (TDM) Protocol
    Natasha Pettit, PharmD ; Randall Knoebel, PharmD ; Zhe Han, PharmD ; Emily Landon, MD ; Jennifer Pisano, MD
    204
    Voriconazole Restriction in Addition to Therapeutic Drug Monitoring (TDM) Protocol Results in Optimized Dosing
    Natasha Pettit, PharmD ; Zhe Han, PharmD ; Mildred Vicente, PharmD ; Emily Landon, MD ; Jennifer Pisano, MD ; Allison H. Bartlett, MD, MS
    205
    Antimicrobial Stewardship Knowledge, Attitudes and Practices among Healthcare Professionals in Utah
    Whitney R. Buckel, PharmD ; Adam L. Hersh, MD, PhD ; Andrew Pavia, MD, FIDSA, FSHEA ; Peter S. Jones, MSLS ; Josh Caraccio, PharmD ; Dustin Waters, PharmD, BCPS ; Ashli Owen-Smith, PhD ; Edward Stenehjem, MD MSc
    Posters
  • KAP Survey Poster v6.pdf (1.0 MB)
  • 206
    Implementing an Antimicrobial Stewardship Program
    Angela Vassallo, MPH, MS ; Snezana Naumovsky, PharmD ; Tanya Elgourt, PharmD ; Robert Winters, MD ; Ellie Goldstein, MD, FIDSA, FSHEA ; John Lee, PharmD
    Posters
  • 2014 ID Week ASP Poster.pdf (427.0 kB)
  • 207
    Metrics for Analyzing an Antimicrobial Stewardship Program’s Impact on Antimicrobial Use and Cost over Time
    Jessica Johnston, MS ; Erica E. Reed, PharmD, BCPS ; Karri a. Bauer, PharmD BCPS ; Kurt Stevenson, MD, MPH
    209
    Results of an Antimicrobial Stewardship Intervention Involving Surgical Subspecialty Patients
    Kati Shihadeh, PharmD ; Michelle Haas, MD ; Philip Mehler, MD ; Marcia Eustaquio, MD ; Timothy Jenkins, MD
    Posters
  • 209_IDWPOSTER.pdf (307.0 kB)
  • 211
    Impact of Focused Medication Cost Reduction Efforts on Antimicrobial Spend
    Erica Reed, PharmD, BCPS ; Jessica Johnston, MS ; Kurt Stevenson, MD, MPH ; Crystal Tubbs, PharmD, FASHP
    212
    Skills Learned during Critical Care Prospective Audit and Feedback are Utilized outside of the Stewardship Environment
    Karim Ali, MD, MBBS ; Gina Dimitra Fleming, BSc. PhM ; Kenny Ma, Bsc. PhM ; Ryan D'sa, MD. FRCPC. FRCP Edin. ; Jeff Powis, MD, MSc, FRCPC
    Posters
  • 212_IDweek.pdf (3.9 MB)
  • 213
    Impact of Antimicrobial Stewardship Strategies on Antimicrobial Use: A Systematic Review
    Yvonne Peijun Zhou, BSc(Pharm)(Hons) ; Nathalie Grace Sy Chua, BSc (Pharm) ; Winnie Lee, BPharm(Hons), MSc (Epi) ; Maciej Piotr Chlebicki, MBBS, ABIM ; Yixin Liew, BSc (Pharm), MSc (ID) ; Andrea Kwa, PharmD
    Posters
  • ASP META ANALYSIS.pdf (986.0 kB)
  • 214
    Social Media as a Tool for Antimicrobial Stewardship
    Jennifer Pisano, MD ; Natasha Pettit, PharmD ; Benjamin Brielmaier, PharmD ; Palak H. Bhagat, PharmD, BCPS ; Zhe Han, PharmD ; Allison H. Bartlett, MD, MS ; Emily Landon, MD
    215
    Impact of Multidisciplinary Antimicrobial Stewardship Rounds on Prospective Audit with Intervention and Feedback Recommendations
    Shaina Bernard, PharmD, BCPS ; Shawn Binkley, BS, PharmD ; David Pegues, MD, FIDSA, FSHEA ; Daniel Timko, PharmD, BCPS, AQID ; Steven Morgan, PharmD, BCPS, AQID ; Keith Hamilton, MD
    216
    Statistical Characterization of Antimicrobial Activity: Do Common Descriptions Hold Up To Unsupervised Data Analytics?
    Joseph Carreno, PharmD ; Stephen Bradley ; Mara Garfinkel ; Joseph Gervasio ; Katherine Lyndaker ; Charles Bergeron, PhD
    217
    The Oregon Antimicrobial Stewardship Collaborative (OASIS). Statewide Effectiveness on Re-Survey
    Jwan Mohammadi ; Lynne Strasfeld, MD ; Melissa Parkerton, MA ; Zintars G. Beldavs, MS ; Robert F. Arao, MPH ; Graeme Forrest, MBBS
    218
    Changes in Antimicrobial Prescribing Patterns Following Implementation of The Oregon Antimicrobial Stewardship Collaborative (OASC)
    Lynne Strasfeld, MD ; Melissa Parkerton, MA ; Robert F. Arao, MPH ; Zintars G. Beldavs, MS ; Katherine Ellingson, PhD ; Jwan Mohammadi ; Ann Thomas, MD, MPH ; Graeme Forrest, MBBS
    219
    Characteristics of Antimicrobial Stewardship (AS) Activities in Community Hospitals Upon Enrollment in the Duke Antimicrobial Stewardship Outreach Network (DASON)
    Myra R. Hawkins, PharmD, BCPS (AQ-ID) ; Richard H. Drew, PharmD, MS, BCPS, FCCP ; Sarah S. Lewis, MD ; Deverick Anderson, MD, MPH ; Daniel J. Sexton, MD, FIDSA ; Rebekah W. Moehring, MD, MPH
    220
    Ongoing Impact of an Antimicrobial Stewardship Program at A Large Academic Medical Center, 7 years of experience
    Susan Kline, MD, MPH ; Kimberly Boeser, Pharm D, BCPS AQ-ID ; Teresa Rakoczy, RN, BSN ; Amanda Guspiel, MPH ; Anita Guelcher, RN, BSN ; Christine Hendrickson, RN, BSN ; Pamela Phelps, Pharm D
    221
    Antimicrobial Use in Nine Intensive Care Units, Using Ten Different Indicators
    Elise Fortin, PhD(c) ; Robert W Platt, PhD ; Patricia Fontela, MD PhD ; Milagros Gonzales, MSc ; David L Buckeridge, MD PhD ; Philippe Ovetchkine, MD MSc ; Caroline Quach, MD MSc FRCPC
    222
    Impact of a City-Wide Collaborative Antimicrobial Management Program Involving All Acute Care Hospitals in Savannah, Georgia
    Nenad Avramovski, MD ; Derek Gaul, PharmD ; William James, MHA ; Charles Jensen, PharmD ; Bruce Jones, PharmD ; Jason Lin, PharmD ; Geneen Gibson, PharmD, MS
    Posters
  • IDSA_Poster_CAMP_Savannah.pdf (247.9 kB)
  • 223
    Teaching Antimicrobial Stewardship Globally with A Massive Online Open Course (MOOC)
    Elizabeth Robilotti, MD MPH ; Emily Mui, PharmD ; Michael Mcauliffe, BA ; Stan Deresinski, MD
    224
    Impact of an Antimicrobial Stewardship Program (ASP) on antimicrobial use and clinical outcomes at a Veterans Affairs (VA) Teaching Hospital
    Haley Morrill, PharmD ; Aisling Caffrey, PhD, MS ; Melissa Gaitanis, MD ; Kerry Laplante, PharmD
    Posters
  • IDweek 2014 ASP.pdf (549.6 kB)
  • 225
    Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence
    Elizabeth Nimmich, MD ; Julie Ann Justo, Pharm D, MS ; P. Brandon Bookstaver, Pharm.D., BCPS, (AQ-ID), AAHIVE ; Katie Devaul, PharmD ; Joseph Kohn, Pharm.D., BCPS ; Sarah Cain, BS ; Geoffrey Turner, MD, PHD ; Helmut Albrecht, MD ; Majdi Al-Hasan, MD
    226
    Impact of Physician Assistant Directed Antimicrobial Stewardship Consultation Service
    Jenny Grunwald, M.S. PA-C ; Rachel Kenney, PharmD ; Allison Weinmann, M.D. ; Laura Johnson, MD ; Jose Vazquez, MD ; Marcus Zervos, MD ; Susan L Davis, PharmD
    227
    Evaluation of Antimicrobial Stewardship in an Academic Medical Center Emergency Department (ED)
    Jennifer Anthone, PharmD ; Barry Nakaoka, PharmD ; Renuga Vivekanandan, MD ; Krysta Baack, PharmD ; John Horne, MD ; Tammy Burns, PharmD
    228
    Building Bridges: Improving Antibiotic Prescribing in the Emergency Department
    Theresa Madaline, MD ; Marta Feldmesser, MD, FIDSA ; Philip Chung, PharmD, MS ; Johanna Daily, MD, MS ; Mahalia Desruisseaux, MD ; Sarah Hochman, MD ; Marla Keller, MD ; Ira Leviton, MD ; Kerry Murphy, MD ; Anjali Sharma, MD ; Scott Pearlman, MD ; Nadine Katz, MD ; Deborah White, MD ; Liise-Anne Pirofski, MD, FIDSA ; Belinda Ostrowsky, MD, MPH
    230
    Antimicrobial Stewardship Strategy to Decrease Respiratory Fluoroquinolone Utilization in a Large, Urban, Healthcare System
    Theresa Jaso, PharmD ; Katherine Shea, PharmD ; Mitchell Daley, PharmD ; Jack Bissett, MD ; Elizabeth Douglass, MD
    231
    Using an Algorithm to Decrease Fluoroquinolone Use and Effects on Escherichia coli Resistance
    Rebecca Seymour, PharmD ; Bryan Knepper, MPH, MSc ; Kati Shihadeh, PharmD ; Mike Doody, PharmD ; Michelle Haas, MD ; Timothy Jenkins, MD
    Posters
  • Seymour_231_IDWeekPoster.pdf (625.3 kB)
  • 233
    Antibiotic Prescribing at the Time of Hospital Discharge: a Target for Antibiotic Stewardship
    Norihiro Yogo, M.D. ; Michelle Haas, MD ; Bryan Knepper, MPH, MSc ; William Burman, MD ; Philip Mehler, MD ; Timothy Jenkins, MD
    234
    Characterization of Inappropriate Antimicrobial Therapy Following Changes in Antimicrobial Stewardship Strategies
    Christine Pham, Pharm.D. ; Jennifer Brown, MD ; Cinda Christensen, Pharm.D., BCPS-ID
    235
    Use of electronic de-escalation alerts to facilitate prospective audit and feedback for antimicrobial stewardship
    Daniel Caroff, MD ; Shawn Binkley, BS, PharmD ; Daniel Timko, PharmD, BCPS, AQID ; Steven Morgan, PharmD, BCPS, AQID ; Shaina Bernard, PharmD, BCPS ; Kiri Rolek, PharmD ; Keith Hamilton, MD
    236
    Taking an Antibiotic Timeout: Utilizing an Antibiotic Renewal Template for Automatic Approval of Vancomycin and Piperacillin-tazobactam
    Christopher J. Graber, MD, MPH, FIDSA ; Makoto Jones, MD, MS ; Kevin Nechodom, BS ; Peter Glassman, MBBS, MSc ; Jorie Butler, PhD ; Charlene Weir, PhD ; Amy Furman, Pharm D. ; Chad Kay, Pharm. D ; Lori Pollack, MD, MPH ; Matthew Samore, MD ; Matthew Bidwell Goetz, MD
    237
    Evaluation of the Impact of a Clinical Decision Support Tool and Pharmacist Telephone Consultation Within 48 hours of Discharge on Unscheduled Emergency Department Encounters for Skin and Soft Tissue Infections
    Christo Cimino, PharmD ; Nishaminy Kasbekar, PharmD, FASHP ; Judith O'donnell, MD ; Christian Boedec ; Christopher Edwards, MD ; Amanda Binkley, PharmD, AAHVIP
    238
    Changing the Culture: Spreading the Stewardship Message to a New Campus
    Julie E. Williamson, PharmD ; Priya Nori, MD ; Marilou Corpuz, MD ; Iona Munjal, MD ; Yi Guo, PharmD ; Philip Chung, PharmD, MS ; Belinda Ostrowsky, MD, MPH
    241
    Effectiveness of a Stewardship Program in Reducing Antimicrobial Use in a Tertiary Care Hospital ICU in Southern Ontario
    Mathew Mercuri, PhD ; Jocelyn a. Srigley, MD, MSc, FRCPC ; Tim Karachi, MD ; Dominik Mertz, MD, MSc
    Posters
  • ID WEEK Poster ICU Sept 15.pdf (452.6 kB)
  • 242
    Stewardship in Community Hospitals – Optimizing Outcomes and Resources (SCORE): A Baseline Analysis of Antimicrobial Use Utilizing CDC NHSN AU Data
    Edward Stenehjem, MD MSc ; Adam L. Hersh, MD, PhD ; Tom Greene, PhD ; Xiaoming Sheng, PhD ; Peter Jones, MSLS ; R Evans, PhD ; Whitney R. Buckel, PharmD ; John Burke, MD ; Andrew Pavia, MD, FIDSA, FSHEA
    243
    Role of a Dedicated Full-time Infectious Diseases Pharmacist in Antimicrobial Stewardship: a Tale of Two Veterans Affairs Medical Centers
    Andrew Ma, MD ; Randolph Fugit, PharmD, BCPS ; Thuong Tran, PharmD ; Mary Bessesen, MD ; Christopher Graber, MD, MPH
    244
    Organizational Factors Associated with Antibacterial Use Among Academic Medical Centers
    Amy Pakyz, PharmD, MS ; Jenna Short ; Hui Wang ; Sam Hohmann
    Posters
  • idweek-9-23.pdf (316.7 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek